The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PISARRO: A EUTROC phase Ib study of APR-246 in combination with carboplatin (C) and pegylated liposomal doxorubicin (PLD) in platinum sensitive relapsed high grade serous ovarian cancer (HGSOC).
 
Charlie Gourley
Honoraria - AstraZeneca; Roche/Genentech
Consulting or Advisory Role - AstraZeneca (Inst); Clovis Oncology (Inst); Nucana (Inst)
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - One patent issued and four pending for a gene expression signature to predict cancer sensitivity to anti-angiogenic therapy. (Inst)
 
John Green
No Relationships to Disclose
 
Hani Gabra
Research Funding - GlaxoSmithKline (Inst)
Patents, Royalties, Other Intellectual Property - Imperial College London (Inst)
 
Ignace Vergote
Consulting or Advisory Role - AstraZeneca (Inst)
 
Bristi Basu
Consulting or Advisory Role - Baxter; Nordic Group
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Bayer
 
James D. Brenton
Stock and Other Ownership Interests - Inivata
Consulting or Advisory Role - Inivata
Speakers' Bureau - AstraZeneca
Patents, Royalties, Other Intellectual Property - TAm-Seq v2 method for ctDNA estimation
Travel, Accommodations, Expenses - Aprea AB; Clovis Oncology
 
Ulf Björklund
Employment - Aprea AB
Leadership - Aprea AB
Stock and Other Ownership Interests - Aprea AB
 
Austin M. Smith
Employment - Theradex
Leadership - Theradex
Stock and Other Ownership Interests - Theradex
 
Mikael Von Euler
Employment - Aprea AB; KDev Oncology
Leadership - Akinion; Axelar; KDev Oncology
Stock and Other Ownership Interests - Roche; Targovax
Consulting or Advisory Role - Akinion (Inst); Aprea AB (Inst); Axelar (Inst); Medix Biochemica; Oncos Therapeutics